SEC Form 4 · accession 0001213900-18-016611
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua R. Disbrow
Officer — Chief Executive Officer · Director
Period of report
Nov 26, 2018
Accepted (ET)
Nov 27, 2018 · 9:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy) | $72.00 | Nov 26, 2018 | P | 5,000 | A | Nov 26, 2018 | Aug 25, 2022 | Common Stock | 5,000 | 5,000 | D |
Remarks
Exhibit 24 - Power of Attorney